Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
adults and children 6 years and over 1 capsule daily; not more than 1 capsule in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
do not use if the individual blister unit is open or torn store between 20° to 25°C (68° to 77°F) protect from freezing FDA approved dissolution test specifications differ from USP
Active ingredient
(in each capsule)
Loratadine USP 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
liver or kidney disease. Your doctor should determine if you need a different dose.
do not take more than directed. Taking more than directed may cause drowsiness.
an allergic reaction to this product occurs. Seek medical help right away.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| adults and children 6 years and over | 1 capsule daily; not more than 1 capsule in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
Gelatin, glycerin, glyceryl monocaprylocaprate, hypromellose, isopropyl alcohol, Neelicert FD&C Blue No.1, polysorbate 80, povidone, propylene glycol, purified water, sorbitol sorbitan solution and titanium dioxide.
call 1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
Distributed by:
AUROHEALTH LLC
279 Princeton-Hightstown Road
East Windsor, NJ 08520
Made in India
Code: TS/DRUGS/22/2009
AUROHEALTH
NDC 58602-818-83
Compare to the active ingredient
in Claritin® Liqui-Gels®†
Non-Drowsy*
Loratadine Capsules USP 10 mg
Antihistamine
Indoor & Outdoor Allergies
Relief of:
24 HOUR
10 Liquid-Filled Capsules
*When taken as directed.
See Drug Facts Panel.
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58602-818-05 | Loratadine | 5 in 1 CARTON | CAPSULE, LIQUID FILLED | 5 | 2 | |
| 58602-818-05 | Loratadine | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 2 | |
| 58602-818-08 | Loratadine | 4 in 1 CARTON | CAPSULE, LIQUID FILLED | 4 | 2 | |
| 58602-818-08 | Loratadine | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 2 | |
| 58602-818-67 | Loratadine | 2 in 1 CARTON | CAPSULE, LIQUID FILLED | 2 | 2 | |
| 58602-818-67 | Loratadine | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 2 | |
| 58602-818-83 | Loratadine | 1 in 1 CARTON | CAPSULE, LIQUID FILLED | 1 | 2 | |
| 58602-818-83 | Loratadine | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 2 | |
| 58602-818-84 | Loratadine | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 2 | |
| 58602-818-84 | Loratadine | 3 in 1 CARTON | CAPSULE, LIQUID FILLED | 3 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58602-818 | 58602-818-83, 58602-818-67, 58602-818-84, 58602-818-08, 58602-818-05 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LORATADINE | 7AJO3BO7QN | ACTIB |
| GELATIN TYPE B BOVINE (160 BLOOM) | 1T8387508X | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| GLYCERYL MONO- AND DICAPRYLOCAPRATE | U72Q2I8C85 | IACT |
| HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | IACT |
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SORBITOL | 506T60A25R | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211900-001 | LORATADINE | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | 053a50430f4f… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211900-001 | LORATADINE | 10MG | CAPSULE / ORAL | 2023-03-24 | a50c72e98297… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loratadine | LORATADINE | Aurohealth LLC | a057241d-a655-4847-9d2d-d45293f45d87 | 2024-10-23 | Warnings | 58602-818-08 58602-818-84 58602-818-67 58602-818-83 58602-818-05 58602-818 58602081808 58602081805 58602081884 58602081867 58602081883 cfa8d72c-3d1a-464c-b63a-b7b7525c1a3c a057241d-a655-4847-9d2d-d45293f45d87 |
Adverse event summaries are temporarily unavailable. Other product information remains available.